Filter Search


Europe


Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Xipamide, Atc C03ba10, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredients Naproxen And Esomeprazole, Atc M01ae52, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Lenograstim, Atc L03aa10, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Sevelamer Hydrochloride, Atc V03ae02, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Tiotropium Bromide, Dosage Form Inhalation Solution, Atc R03bb04, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Loperamide, Atc A07da03, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Buserelin, Atc L02ae01, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Fusidic Acid, Atc D06ax01, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Open House Drug Discount Agreements For The Active Ingredient Sotalol, Atc C07aa07, 67304 Eisenberg Rhineland-palatinate 2026-06-11
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Brimonidine + Timolol, Atc S01ed69 For The Period February 1st, 2026 - January 31st, 2028 (plus Extension Option 1x12 Months) 2026-06-12
Whats app